Mark Ahlman, MD

Mark Ahlman, MD, is a professor of radiology and the division director of nuclear medicine and molecular imaging at UVA Health. He is also a physician-scientist with expertise in translational molecular imaging, theranostics, and advanced PET-based applications.

Dr. Ahlman’s clinical activities include:

• Diagnostic interpretation of PET, SPECT, and hybrid imaging (PET/CT, SPECT/CT) across oncology, cardiology, neurology, and inflammatory disease
• Radionuclide therapy for cancer and benign conditions, including targeted theranostic treatments
• Leadership in nuclear medicine service lines, ensuring integration of cutting-edge imaging and therapeutic approaches into patient care

Much of Dr. Ahlman’s academic work has focused on innovation in cardiovascular and inflammatory disease imaging, as well as technical development in PET. His NIH and institutional collaborations have advanced coronary PET-MR imaging through simultaneous cardiac and respiratory motion correction, numerous oncology applications, as well as FDG-PET approaches for vascular inflammation research.

Dr. Ahlman is deeply engaged in medical education, mentoring residents, fellows, and junior faculty, while also contributing to national and international committees shaping the field of nuclear medicine. At UVA, he is committed to expanding access to PET and theranostics and building cross-disciplinary collaborations in molecular imaging.

Gender

Male

Languages

English

Age Groups Seen

Infants (0-2)
Children (2-12)
Adolescents (12-21)
Adults (21-65)
Older Adults (65+)

Primary Education

Medical College of Georgia at Georgia Health Sciences University

Residency

Medical University of South Carolina

Fellowships

National Institutes of Health Clinical Center

Certification

American Board of Nuclear Medicine (Nuclear Medicine)

Additional Specialties

Diagnostic Radiology